Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Clinical trial NCT05997017 · RECRUITING

Trial details

NCT number: NCT05997017
Sponsor: Aadi Bioscience, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Endometrioid Tumor Cancer Tumor Recurrent Endometrial Carcinoma Endometrioid Endometrial Cancer

Start date: 2023-12-28
Primary completion: 2026-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.